| Literature DB >> 27184752 |
Megan McNamara1, Pelin Batur2, Judith M E Walsh3, Kay M Johnson4.
Abstract
Human papillomavirus (HPV) infection is the causative agent in cervical cancer, and is associated with numerous other genital cancers, including vulvar, vaginal, and anal cancer. Primary prevention with HPV vaccination is safe and efficacious, and a recently approved HPV vaccine will provide even more extensive protection against several oncogenic HPV strains. Screening strategies for HPV are rapidly evolving, reflecting the essential role that HPV infection plays in cervical cancer. This article highlights new evidence regarding the efficacy of the recently approved 9-valent HPV (9vHPV) vaccine and the use of primary high-risk HPV testing in cervical cancer screening. We consider the utility of urinary HPV testing in routine clinical practice and review current guidelines regarding anal HPV screening.Entities:
Keywords: HPV; cervical cancer; prevention; screening; vaccination
Mesh:
Substances:
Year: 2016 PMID: 27184752 PMCID: PMC5071275 DOI: 10.1007/s11606-016-3725-z
Source DB: PubMed Journal: J Gen Intern Med ISSN: 0884-8734 Impact factor: 5.128